Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 378

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 378
---
, et al. (2018). Post-Thrombolysis Recanalization             
 in Stroke Referrals for Thrombectomy Tsivgoulis G, Katsanos AH, Schellinger PD, Köhrmann M, Varelas P, Magoufis G, Paciaroni                               
 M, Caso V, Alexandrov AW, Gurol E, et al. (2018). Successful Reperfusion with Intravenous Thrombolysis Preceding Mechanical Thrombectomy                   
 in Large-Vessel Occlusions. American Heart Association, 49:232-235                                                                                         |

| 203 |

Facilities

Our corporate headquarters is located in Bothell, Washington where Cerevast is also headquartered. Cerevast leases approximately 6,287 square feet of office and research and development laboratory space pursuant to a lease agreement which commenced on November 1, 2018 and expires on January 31, 2026. We intend to assume this lease upon completion of the Business Combination.

The laboratories support research, development, acoustic testing and prototype development. We will use these laboratories to perform all non-GMP analytical methods related to formulation characterization and release specifications as well as pilot scale production. We will also utilize our existing laboratory facilities for general engineering and device testing activities.

We anticipate that our current facilities will be sufficient to meet our office and laboratory space needs for the subsequent 12 to 24 months following the completion of the Business Combination.

Human Capital

We are fostering an inclusive, collaborative culture committed to realizing our mission upon completion of the Target Acquisitions and the Business Combination — to become the leading provider of products and services to help people live longer, healthier lives. Our core values include:

| ● | Innovation                                                                                                                   
 — We strive to use proven science to develop breakthrough medical therapies that extend and improve the quality of patients’ 
 lives.                                                                                                                       |

| ● | Drive                                                                                                                      
 — We are committed to the relentless pursuit of achieving our goals. Always moving forward, we celebrate our successes and 
 learn from our mistakes.                                                                                                   |

| ● | Integrity                                                                                     
 and Ethics — We strive to always do the right thing, in an honest, fair, and responsible way. |

| ● | Respect                                                                                                                                 
 — We are committed to demonstrating the utmost respect to our employees, customers, and stakeholders. We respect individual             
 human rights and oppose all kinds and forms of discrimination, whether based on religion, belief, race, ethnicity, nationality, gender, 
 sexual orientation, or physical